Evercore ISI Cuts Agilon Health (NYSE:AGL) Price Target to $3.00

Agilon Health (NYSE:AGL - Free Report) had its price target decreased by Evercore ISI from $5.00 to $3.00 in a research report released on Wednesday morning,Benzinga reports. Evercore ISI currently has an in-line rating on the stock.

Several other research analysts have also issued reports on the company. Cowen restated a "hold" rating on shares of Agilon Health in a research report on Tuesday, April 15th. Sanford C. Bernstein upgraded Agilon Health from a "market perform" rating to an "outperform" rating and lifted their target price for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Wells Fargo & Company reduced their target price on Agilon Health from $6.00 to $5.00 and set an "overweight" rating on the stock in a report on Tuesday, May 13th. Needham & Company LLC reiterated a "hold" rating on shares of Agilon Health in a report on Friday, March 21st. Finally, JMP Securities reiterated a "market perform" rating on shares of Agilon Health in a report on Monday, April 28th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Agilon Health currently has an average rating of "Hold" and an average target price of $4.71.

Agilon Health Price Performance

Shares of AGL traded up $0.03 during mid-day trading on Wednesday, reaching $2.32. The company had a trading volume of 3,375,495 shares, compared to its average volume of 4,801,406. The company's 50-day moving average is $2.48 and its 200-day moving average is $3.23. Agilon Health has a twelve month low of $1.50 and a twelve month high of $7.73. The company has a market capitalization of $958.29 million, a P/E ratio of -3.92 and a beta of 0.16.

Agilon Health (NYSE:AGL - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.04. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The company had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same period last year, the firm earned ($0.02) EPS. The business's revenue for the quarter was down 4.5% on a year-over-year basis. As a group, equities analysts expect that Agilon Health will post -0.59 EPS for the current fiscal year.

Institutional Trading of Agilon Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. Signaturefd LLC increased its position in shares of Agilon Health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after acquiring an additional 8,467 shares during the last quarter. Humankind Investments LLC acquired a new stake in shares of Agilon Health in the fourth quarter valued at about $30,000. Raymond James Financial Inc. acquired a new stake in shares of Agilon Health in the fourth quarter valued at about $33,000. Cerity Partners LLC acquired a new stake in shares of Agilon Health in the fourth quarter valued at about $34,000. Finally, Nisa Investment Advisors LLC increased its position in shares of Agilon Health by 244.9% in the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock valued at $41,000 after acquiring an additional 6,783 shares during the last quarter.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.